Clinical Evaluation of a Novel CGM-Informed Bolus Calculator with Automatic Glucose Trend Adjustment
- PMID: 34491825
- PMCID: PMC8783627
- DOI: 10.1089/dia.2021.0140
Clinical Evaluation of a Novel CGM-Informed Bolus Calculator with Automatic Glucose Trend Adjustment
Abstract
Background: Expert opinion guidelines and limited data from clinical trials recommend adjustment to bolus insulin doses based on continuous glucose monitor (CGM) trend data, yet minimal evidence exists to support this approach. We performed a clinical evaluation of a novel CGM-informed bolus calculator (CIBC) with automatic insulin bolus dose adjustment based on CGM trend used with sensor-augmented pump therapy. Materials and Methods: In this multicenter, outpatient study, participants 6-70 years of age with type 1 diabetes (T1D) used the Omnipod® 5 System in Manual Mode, first for 7 days without a connected CGM (standard bolus calculator, SBC, phase 1) and then for 7 days with a connected CGM using the CIBC (CIBC phase 2). The integrated bolus calculator used stored pump settings plus user-estimated meal size and/or either a manually entered capillary glucose value (SBC phase) or an imported current CGM value and trend (CIBC phase) to recommend a bolus amount. The CIBC automatically increased or decreased the suggested bolus amount based on the CGM trend. Results: Twenty-five participants, (mean ± standard deviation) 27 ± 15 years of age, with T1D duration 12 ± 9 years and A1C 7.0% ± 0.9% completed the study. There were significantly fewer sensor readings <70 mg/dL 4 h postbolus with the CIBC compared to the SBC (2.1% ± 2.0% vs. 2.8 ± 2.7, P = 0.03), while percent of sensor readings >180 and 70-180 mg/dL remained the same. There was no difference in insulin use or number of boluses given between the two phases. Conclusion: The CIBC was safe when used with the Omnipod 5 System in Manual Mode, with fewer hypoglycemic readings in the postbolus period compared to the SBC. This trial was registered at ClinicalTrials.gov (NCT04320069).
Keywords: Bolus calculator; Continuous glucose monitoring; Hypoglycemia; Omnipod; Type 1 diabetes.
Conflict of interest statement
J.E.P. reports grant support and supplies, provided to his institution, from Insulet Corporation; grant support, provided to his institution, and consulting fees and speaker fees from Tandem Diabetes Care, Inc.; grant support, provided to his institution, and advisory board fees from Medtronic; grant support, provided to his institution, and consulting fees from Eli Lilly; and supplies, provided to his institution, from Dexcom, Inc., S.A.B. reports grants from Insulet, nonfinancial support from Dexcom, during the conduct of the study; grants and supplies from Tandem Diabetes Care, nonfinancial support from Roche Diagnostics; grants from Tolerion; and grants and supplies from Dexcom outside the submitted work. B.W.B. reports grant support to his employer Atlanta Diabetes Associates. M.K.V. reports grant support from Medtronic, Insulet, Tolerion, DexCom.; Speaker Panel for Abbott, DexCom; Past Employment Medtronic Diabetes. T.T.L., B.D., L.M.H., J.B.L., and E.B. are full-time employees of and own stock in Insulet Corporation. J.O. is a full-time employee of and owns stock in Insulet Corporation, and holds multiple patents related to the product used in the trial. M.M.C. and B.N. have nothing to disclose. No other conflicts of interest were reported.
Figures


Similar articles
-
Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus.Diabetes Technol Ther. 2018 Aug;20(8):531-540. doi: 10.1089/dia.2018.0079. Epub 2018 Jul 6. Diabetes Technol Ther. 2018. PMID: 29979618 Free PMC article. Clinical Trial.
-
The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.JBI Libr Syst Rev. 2012;10(42 Suppl):1-10. doi: 10.11124/jbisrir-2012-170. JBI Libr Syst Rev. 2012. PMID: 27820140
-
The Use of a Smart Bolus Calculator Informed by Real-time Insulin Sensitivity Assessments Reduces Postprandial Hypoglycemia Following an Aerobic Exercise Session in Individuals With Type 1 Diabetes.Diabetes Care. 2020 Apr;43(4):799-805. doi: 10.2337/dc19-1675. Epub 2020 Mar 6. Diabetes Care. 2020. PMID: 32144167 Free PMC article. Clinical Trial.
-
Diabetes technology and treatments in the paediatric age group.Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Int J Clin Pract Suppl. 2011. PMID: 21323816 Review.
-
Personal continuous glucose monitoring (CGM) in diabetes management: review of the literature and implementation for practical use.Diabetes Res Clin Pract. 2012 Jun;96(3):294-305. doi: 10.1016/j.diabres.2011.12.010. Epub 2011 Dec 28. Diabetes Res Clin Pract. 2012. PMID: 22209014 Review.
Cited by
-
A Head-to-Head Comparison of Two Algorithms for Adjusting Mealtime Insulin Doses Based on CGM Trend Arrows in Adult Patients with Type 1 Diabetes: Results from an Exploratory Study.Int J Environ Res Public Health. 2023 Feb 23;20(5):3945. doi: 10.3390/ijerph20053945. Int J Environ Res Public Health. 2023. PMID: 36900956 Free PMC article. Clinical Trial.
-
Evidence from clinical trials on high-risk medical devices in children: a scoping review.Pediatr Res. 2024 Feb;95(3):615-624. doi: 10.1038/s41390-023-02819-4. Epub 2023 Sep 28. Pediatr Res. 2024. PMID: 37758865 Free PMC article.
-
Using Continuous Glucose Monitoring Values for Bolus Size Calculation in Smart Multiple Daily Injection Systems: No Negative Impact on Post-bolus Glycemic Outcomes Found in Real-World Data.J Diabetes Sci Technol. 2025 May;19(3):642-648. doi: 10.1177/19322968231202803. Epub 2023 Sep 24. J Diabetes Sci Technol. 2025. PMID: 37743727 Free PMC article.
-
Safety of a Novel Continuous Glucose Monitoring-Informed Insulin Bolus Calculator Mobile Application for People With Type 1 or Type 2 Diabetes.Diabetes Spectr. 2024 Nov 11;38(2):153-160. doi: 10.2337/ds24-0032. eCollection 2025 Spring. Diabetes Spectr. 2024. PMID: 40386812 Free PMC article.
-
Continuous Glucose Monitoring and Bolus Calculators: A Good Combination.J Diabetes Sci Technol. 2024 Jul;18(4):761-763. doi: 10.1177/19322968231204371. Epub 2023 Oct 7. J Diabetes Sci Technol. 2024. PMID: 37804180 Free PMC article. No abstract available.
References
-
- Bassi M, Minuto N, Fichera G, et al. : Practical approach to using trend arrows on real-time continuous glucose monitoring system in type 1 diabetes adolescents living camp setting treated with multiple daily injection or continuous subcutaneous insulin infusion insulin therapy. J Diabetes Sci Technol 2020:1932296820934803. - PMC - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical